CN116716335A - Application of dandelion TmABI5 gene in promoting plant to synthesize chicoric acid - Google Patents
Application of dandelion TmABI5 gene in promoting plant to synthesize chicoric acid Download PDFInfo
- Publication number
- CN116716335A CN116716335A CN202310640364.5A CN202310640364A CN116716335A CN 116716335 A CN116716335 A CN 116716335A CN 202310640364 A CN202310640364 A CN 202310640364A CN 116716335 A CN116716335 A CN 116716335A
- Authority
- CN
- China
- Prior art keywords
- dandelion
- gene
- tmabi5
- chicoric acid
- synthesize
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 68
- 241000245665 Taraxacum Species 0.000 title claims abstract description 60
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 title claims abstract description 57
- 241000196324 Embryophyta Species 0.000 title claims abstract description 28
- YDDGKXBLOXEEMN-IABMMNSOSA-L Chicoric acid Natural products C1=C(O)C(O)=CC=C1\C=C\C(=O)O[C@@H](C([O-])=O)[C@H](C([O-])=O)OC(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-L 0.000 title claims abstract description 27
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 title claims abstract description 27
- 229930016920 cichoric acid Natural products 0.000 title claims abstract description 27
- YDDGKXBLOXEEMN-PMACEKPBSA-N dicaffeoyl-D-tartaric acid Natural products O([C@H](C(=O)O)[C@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-PMACEKPBSA-N 0.000 title claims abstract description 27
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 title claims abstract description 27
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 title claims abstract description 26
- 230000001737 promoting effect Effects 0.000 title claims abstract description 11
- 230000014509 gene expression Effects 0.000 claims abstract description 17
- 230000009261 transgenic effect Effects 0.000 claims abstract description 15
- 239000013604 expression vector Substances 0.000 claims abstract description 10
- 239000013598 vector Substances 0.000 claims description 12
- 230000009466 transformation Effects 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 6
- 241000589158 Agrobacterium Species 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 3
- 230000001052 transient effect Effects 0.000 claims 1
- 238000004458 analytical method Methods 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 4
- 238000013518 transcription Methods 0.000 abstract description 3
- 230000035897 transcription Effects 0.000 abstract description 3
- 238000010367 cloning Methods 0.000 abstract description 2
- 230000002018 overexpression Effects 0.000 abstract description 2
- 238000009395 breeding Methods 0.000 abstract 1
- 230000001488 breeding effect Effects 0.000 abstract 1
- 238000010353 genetic engineering Methods 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000010276 construction Methods 0.000 description 6
- 108091023040 Transcription factor Proteins 0.000 description 5
- 102000040945 Transcription factor Human genes 0.000 description 5
- 150000007965 phenolic acids Chemical class 0.000 description 5
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 4
- 101150029435 4CL gene Proteins 0.000 description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 4
- 229960004261 cefotaxime Drugs 0.000 description 4
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 4
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 4
- 229940074393 chlorogenic acid Drugs 0.000 description 4
- 235000001368 chlorogenic acid Nutrition 0.000 description 4
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 4
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 4
- 239000013599 cloning vector Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 241000292546 Taraxacum mongolicum Species 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- -1 phenolic acid compounds Chemical class 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- 101150017339 ABI5 gene Proteins 0.000 description 2
- 108010001572 Basic-Leucine Zipper Transcription Factors Proteins 0.000 description 2
- 102000000806 Basic-Leucine Zipper Transcription Factors Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000004960 subcellular localization Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- 229940093681 4-coumaric acid Drugs 0.000 description 1
- 101150001464 4CL1 gene Proteins 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- SWGKAHCIOQPKFW-JTNORFRNSA-N Caftaric acid Chemical compound OC(=O)[C@H](O)[C@H](C(O)=O)OC(=O)\C=C\C1=CC=C(O)C(O)=C1 SWGKAHCIOQPKFW-JTNORFRNSA-N 0.000 description 1
- 101100338494 Chlamydia trachomatis serovar L2 (strain 434/Bu / ATCC VR-902B) hctB gene Proteins 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000005870 Coenzyme A Ligases Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 101150066002 GFP gene Proteins 0.000 description 1
- 101150085952 HTT1 gene Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101100338495 Oryza sativa subsp. japonica HCT2 gene Proteins 0.000 description 1
- 101150072055 PAL1 gene Proteins 0.000 description 1
- 101100219263 Petunia hybrida C4H1 gene Proteins 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 101100192827 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PXA1 gene Proteins 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 101100152611 Sorghum bicolor CYP73A33 gene Proteins 0.000 description 1
- 241000583907 Taraka Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 102000039554 bZIP family Human genes 0.000 description 1
- 108091067354 bZIP family Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 239000012881 co-culture medium Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 239000003864 humus Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 101150077062 pal gene Proteins 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000002243 precursor Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012883 rooting culture medium Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
The invention discloses an application of dandelion TmABI5 gene in promoting plants to synthesize chicoric acid, and belongs to the technical field of plant molecular biology. According to the invention, dandelion leaves are used as materials, dandelion TmABI5 genes are obtained through cloning, an over-expression vector pHellgate-TmABI 5-GFP is constructed on the basis, and the dandelion leaves are transferred into dandelion to obtain transgenic plants. The analysis result of the chicoric acid content shows that the chicoric acid content of the transgenic plant is obviously higher than that of the control group; the gene function identification result shows that the TmABI5 gene activates the expression of the Tm4CL1 gene in dandelion through transcription, and the content of chicoric acid is increased. The TmABI5 gene can be used as an important gene for carrying out genetic engineering and improved breeding of dandelion.
Description
Technical Field
The invention belongs to the technical field of plant molecular biology, and particularly relates to an application of dandelion TmABI5 gene in promoting plant to synthesize chicoric acid.
Background
Dandelion (Taraxacum mongolicum hand-mazz.) originates in the middle east and spreads throughout the country, belonging to the genus Taraxacum (Taraxacum f.h.wigg.) of the family Asteraceae. The dandelion contains rich chicoric acid, chlorogenic acid, dandelionsterol and other components, and has the functions of resisting bacteria, diminishing inflammation, resisting oxidation, promoting urination, preventing cancer and other medicine effects. Phenolic acid materials are involved in the formation and development of flowers, fruits, seeds and other functions in plants, such as antioxidant activity, protection against biological and non-biological attack by plant pathogens. The phenolic acid compounds which are studied in the current stage are mainly chlorogenic acid, caffeic acid, chicoric acid, salicylic acid and the like. Therefore, the identification of transcription factors involved in the synthesis and regulation of phenolic acids is of great biological and industrial significance.
The phenolic acid synthesis pathway in plants mainly originates from the phenylalanine pathway, which involves multiple enzymes, but the last step of the enzymatic reaction in the first three steps of the phenylalanine pathway has the synthase gene of 4-coumaric acid: coenzyme A ligase (4 CL gene), 4CL gene is the key switch of phenolic acid synthesis downstream, 4CL gene has been cloned and well analyzed in Arabidopsis thaliana, tomato, potato, grape, echinacea and other multiple plants, and 4CL gene expression level is regulated by transcription factors. Transcription factors are typically capable of binding to cis-acting elements on structural gene promoters to regulate expression of structural genes. Wherein the bZIP transcription factor activates the phenolic acid multiple synthase gene promoters to regulate biosynthesis of phenolic acid compounds. However, the bZIP transcription factor in dandelion has not been reported to regulate the metabolic pathway of dandelion chicoric acid. The ABI5 transcription factor has been reported to bind to the 4CL gene promoter. Thus, it is presumed that there is a pathway in dandelion in which the ABI5 transcription factor activates the 4CL promoter and thus controls dandelion chicoric acid biosynthesis.
Disclosure of Invention
Aiming at the problems in the prior art, the invention aims to provide the application of the dandelion TmABI5 gene in promoting the plant to synthesize chicoric acid, thereby improving the quality of dandelion.
In order to solve the technical problems, the technical scheme adopted by the invention is as follows:
the application of the dandelion TmABI5 gene in promoting dandelion to synthesize chicoric acid is provided, and the nucleotide sequence of the dandelion TmABI5 gene is shown in SEQ ID NO. 1.
The application of the dandelion TmABI5 gene in promoting dandelion to synthesize chicoric acid comprises the following steps:
(1) Constructing a carrier of a dandelion TmABI5 gene;
(2) Transforming the constructed dandelion TmABl5 gene vector into dandelion;
(3) And (5) culturing and screening to obtain the transgenic dandelion with increased chicoric acid content.
The transformation is genetic transformation mediated by agrobacterium.
The vector is a plant expression vector.
The plant expression vector is pHellgate-TmABI 5-GFP.
The application of the dandelion TmABI5 gene in promoting the expression of the Tm4CL1 gene is provided, and the nucleotide sequence of the dandelion TmABI5 gene is shown as SEQ ID NO. 1.
Compared with the prior art, the invention has the beneficial effects that:
according to the invention, dandelion leaves are used as materials, dandelion TmABI5 genes are obtained through cloning, an over-expression vector pHellgate-TmABI 5-GFP is constructed on the basis, and the dandelion leaves are transferred into dandelion to obtain transgenic plants. The analysis result of the chicoric acid content shows that the chicoric acid content of the transgenic dandelion is obviously higher than that of the control group; the gene function identification result shows that the TmABI5 gene activates the expression of the Tm4CL1 gene in dandelion through transcription, and the content of chicoric acid is increased.
Drawings
FIG. 1 is a pHelsgate-TmABI 5-GFP vector construction;
FIG. 2 shows a map of subcellular localization of the TmABI5 gene protein in tobacco leaf cells;
FIG. 3 shows a flow chart of genetic transformation of dandelion;
FIG. 4 is a PCR identification map of TmABI5 overexpressing transgenic dandelion;
FIG. 5 is a graph showing analysis of the expression level of TmABI5 gene in over-expressed dandelion;
FIG. 6 is a graph of the content analysis of TmABI5 transgenic dandelion chlorogenic acid, tartaric acid and chicoric acid;
FIG. 7 is a diagram showing the verification of TmABI5 binding to Tm4CL1 gene promoter by single hybridization of yeast and Dual-LUC test.
Detailed Description
The present invention will be further described with reference to specific embodiments for the purpose of making the objects, technical solutions and advantages of the present invention more apparent. Unless otherwise indicated, all technical means used in the following examples are conventional means well known to those skilled in the art.
The plant material adopted by the invention is dandelion with the size of 2 months, the illumination is 8/16h, and the illumination intensity is 2000-30001x.
Example 1: taraxacum mongolicum TmABI5 gene clone
1. Primer design
The present invention screens sequences for homology higher than 60% in existing transcriptome databases (NCBI accession number: PRJNA 861012) and genomic data (Lin, T et al 2022) based on reported AB15 gene sequences in other species using local blast alignment. According to the coding sequence of TRITY_DN 564_c0_g2, the Primer design is carried out by utilizing an online sequence Primer 5, wherein the Primer sequence is as follows:
TmABI5-F:5’-ATGAGTTCGTTTATCAACTTC-3’,
TmABI5-R:5’-CTACCATGGCCCTGTTAATG-3’。
2. gene cloning and recovery of target fragment
Total RNA of dandelion leaves was extracted using a polysaccharide polyphenol plant total RNA extraction kit produced by TARAKA company, and the specific method is referred to in the specification.
Taraxacum mongolicum leaf RNA was reverse transcribed into cDNA using an RNA reverse transcription kit manufactured by the full gold company.
Using the cDNA synthesized by reverse transcription as a template, the PCR system was carried out according to a conventional PCR system (12.5. Mu.L mix, 11.5. Mu. L H) 2 O, 0.5. Mu.L of each of the upstream and downstream primers, 1. Mu.L of the template, 25. Mu.L in total) and a PCR reaction program (pre-denaturation 94℃for 3min;30 cycles: denaturation at 94℃for 30s, annealing at 52℃for 30s, and extension at 72℃for 30s; and finally, the time is prolonged for 10min at 72 ℃) to clone and obtain the target gene. The size of the target fragment is between 1000 and 1500 bp. After completion of the reaction, the amplified product was purified by 1Separating by electrophoresis with% agarose gel; the correct size strips were excised and recovered and purified using a TAKARA gel recovery kit.
3. Construction of cloning vector and transformation of E.coli
Recovery of the product the target gene was ligated into the cloning vector using a conventional Ta cloning vector kit and transformed into e.coli DH5a, and positive identification of the monoclonal strain was performed using primers M13F (5'-CGCCAGGGTTTTCCCAGTCACGAC-3') and TmABI5R (5'-CTACCATGGCCCTGTTAATG-3'). The PCR identified correct (1000-1500 bp) strain was sent to Shanghai Biotechnology Co., ltd for sequencing, and the nucleotide sequence of the Taraxacum TmABI5 gene (NCBI accession number: 2706189) is shown in SEQ ID NO. 1.
Example 2: construction and function verification of dandelion TmABI5 gene expression vector
1. Construction of fusion expression vectors
And (3) using the constructed cloning vector as a template, redesigning a vector construction primer to amplify the target gene, so that the upper and lower streams of the target gene are provided with XhoI enzyme cutting sites, and performing single enzyme cutting on pHellgate-GFP stored in a laboratory by using XhoI enzyme to recover the target gene and a large vector fragment (the vector construction is shown in figure 1). The sequence of the desired primer is as follows:
G1-TmABI5-F:
5’-TTTGGAGAGGACACGCTCGAGATGAGTTCGTTTATCAACTTC-3’,
G1-TmABI5-R:
5’-GCTCACCATGAATTCCTCGAGCCATGGCCCTGTTAATG-3’。
TmABI5 was ligated into pHellgate-GFP vector using a noniprandial homologous recombination kit according to the instructions, and DH5a strain was transformed and then subjected to conventional positive identification to obtain a plant fusion expression vector pHellgate-TmABI 5-GFP. Positive identification and sequencing analysis were performed using 35S-F (5'-GACGCACAATCCCACTATCC-3') and the target gene downstream primer TmAB15-R (5'-CTACCATGGCCCTGTTAATG-3'). The strain with the correct sequencing result is subjected to plasmid extraction for standby.
2. Tobacco subcellular localization
Dividing the constructed recombinant plasmid and the control plasmidAnd (3) transforming the agrobacterium GV3101 strain, and selecting a positive strain after colony PCR verification is correct, and placing the correct positive strain in a refrigerator at 4 ℃ for later use. Preparation of Agrobacterium solution culturing according to conventional culture conditions to OD 600 =0.8-1.0。
Adding 100 mu M acetosyringone into the cultured bacterial liquid, and after light shielding for 2 hours, injecting the bacterial liquid into the surface skin of the back of the tobacco leaf by using a 1mL syringe, and observing 35S after light shielding for 48-72 hours: tmABI5: GFP fusion protein.
The results are shown in FIG. 2, and the laser confocal microscope observation is carried out at 35S: tmABI5: GFP fusion proteins localize to the nucleus consistent with other members of the bZIP family of other subfamilies a.
3. Agrobacterium-mediated transformation of dandelion
Sterilizing herba Taraxaci seeds stored in laboratory with 75% ethanol for 5-10min, washing with sterile water for 3 times, sucking dry filter paper, and placing on MS solid culture medium plate with sterilized filter paper; growing for 1 week to root length of 2-3cm, transferring 2-4 leaves to a culture flask (250 mL), and continuing to grow for 2 months; cutting the healthy dandelion leaves with a sterile scalpel to a leaf size of 0.5-1cm 2 Pre-culturing for 48-72h, wherein the pre-culturing culture medium is MS solid culture medium; the GV3101 strain containing pHellsgate-TmABI5-GFP fusion expression vector is subjected to conventional activation culture, and the bacterial solution is cultured to OD 600 =0.8-1.0; suspending the pre-cultured dandelion leaves for 3-5min by using agrobacterium tumefaciens bacteria solution, sucking the leaves to dryness by using sterile filter paper, transferring the leaves to a co-culture medium (MS solid medium), and culturing the leaves in darkness for 48-72h; leaf placement callus induction (MS+0.1 mg/L6-BA+2 mg/L NAA+30.0g/L sucrose+7.0 g/L agar+50 mg/L Kan+500mg/L cefotaxime) after co-cultivation for about 2-3 weeks; transferring the induced callus to bud induction culture medium (MS+2mg/L6-BA+0.2 mg/L NAA+30.0g/L sucrose+7.0 g/L agar+50 mg/L Kan+500mg/L cefotaxime), growing for about 4-6 weeks, and decreasing the concentration of cefotaxime antibiotics every week (gradient is 400, 300, 200, 100 in sequence); transferring to rooting culture medium (1/2MS+2 mg/L6-BA+0.2 mg/L NAA+30.0g/L sucrose+7.0 g/L agar+50 mg/L Kan+100mg/L cefotaxime) after the buds grow to 3-5cm for about 4-5 weeks; hardening seedlings of dandelion with good rooting for 3-5 days, and transferring to a soil matrix(humus/vermiculite = 3/1). And finally, obtaining 19 transgenic lines to be identified, wherein the 19 transgenic lines grow well.
4. Transgenic plant detection
According to the instruction of the root plant genome DNA extraction kit, extracting the DNA of 19 dandelion leaves with good growth obtained in the above way, and carrying out gene detection. Primers Kan-F (5'-ATGGCAATTACCTTATCCGC-3') and Kan-R (5'-TCAGAAGAACTCGTCAAGAAG-3') carried by the strain and upstream and downstream of the Kan+ gene are used; the GFP-F (5'-ATGGTGAGCAAGGGCGAGGAG-3') and GFP-R (5'-TTACTTGTACAGCTCGTCCATG-3') primers were used to identify the presence of Kan+ and GFP genes in wild type plants, empty control plants and positive plants, respectively. The results show that the wild type does not contain Kan+ gene and GFP gene; the empty control plants and the positive plants contain Kan+ genes and GFP genes.
Positive plants were further screened using vector 35S promoter primer 35S-F (5'-GACGCACAATCCCACTATCC-3') and target gene downstream primer TmABI5-R (5'-CCATGGCCCTGTTAATG-3').
As a result, as shown in FIG. 3, 4 positive TmABI5 transgenic lines (OE 1-4) and 1 Empty Vector (EV) control lines were obtained by screening.
The gene expression levels of TmABI5 in the different strains were further analyzed using qRT-PCR using qRT-TmABI5-F (5'-TTCAACCGCAAATCACAGAG-3') and qRT-TmABI5-R (5'-TGGAGATCCAGCACCAAGAC-3'), internal reference genes are Actin-F (5'-AGCAGCTTCCATTCCGATCA-3') and Actin-R (5'-GGTTACATGTTCACCACCAC-3'), quantitative test methods reference (Liu et al, 2021).
As a result, as shown in FIG. 4, the expression level of the TmABI5 gene was significantly higher in each of the 4 over-expressed strains (OE 1-4) than in the empty vector control strain (EV 1).
Example 3
10mL of dry samples (OE 1-4 and EV 1-3) were weighed and extracted in an ultrasonic apparatus (Qsonic 700, USA) with 1mL of 70% methanol (v/v) at an amplitude of 50%,40s/20s at 4℃for a total of 15min. The extract was centrifuged at 5000 Xg for 10min at 4℃and the supernatant was collected. The residue was extracted again using the same conditions. Both supernatants were combined and diluted to 2.5mg/mL (dry matter and solvent). Agilent 1100 high performance liquid chromatography was used with Phenomenex Gemoni u C18 110A (250X 4.6mm,5 μm) as a liquid chromatography column. The flow rate was kept at 1.0mL/min and absorbance was measured by a UV detector at a wavelength of 254 nm. Three replicates were performed. The chlorogenic acid, monocaffeoyltartaric acid and chicoric acid contents in the obtained 4 transgenic lines were examined.
The liquid phase conditions are as follows: the mobile phase was 0.1% formic acid water (a) and acetonitrile (B). The gradient is as follows: 2% B,0.5min;2-14% B,1min;14-18% B,5.5min;18-80% B,2min;80% B,1min, and then the column was rebalanced with 2% B for 3min.
The results are shown in FIG. 5, where the content of chicoric acid in the transgenic line OE4 is significantly higher than in the other transgenic lines; the content of chicoric acid in the empty control strain EV1 is 16.68+/-2.85 mg/g, which is obviously higher than that of other empty control strains.
Example 4
And (3) carrying out chicoric acid synthetase gene expression analysis on the OE4 strain and the EV1 strain obtained by screening.
Results as shown in fig. 6, PAL1, C4H1, 4CL1, HCT2 and HQT/HTT1 gene expression levels were significantly higher in OE4 lines than in EV1 lines, thus concluding that: the TmABI5 gene promotes the expression of the genes so as to improve the content of chicoric acid and precursor compounds thereof, the expression pattern of the TmABI5 gene is consistent with that of the Tm4CL1 gene, and the TmABI5 gene can promote the expression of the Tm4CL1 gene.
Example 5
The forward 1564bp region of the Tm4CL1 promoter was obtained using chromosome walking (RACE technique) and was found to contain 1 ABRE cis-motif and 2G-box like motif, respectively. Further validation was performed using a yeast single hybridization experiment.
As a result, as shown in FIG. 7A, the TmABI5 gene is capable of binding to ABRE cis-motif; this suggests that the TmABI5 gene is capable of binding to the Tm4CL1 promoter; the results are shown in FIG. 7B, and the Dual-LUC results show that the TmABI5 gene promotes the expression of the Tm4CL1 gene.
Based on the above analysis, it was concluded that: the TmABI5 gene activates the expression of the Tm4CL1 gene in dandelion through transcription, so that the content of chicoric acid is increased.
Claims (6)
1. The application of the dandelion TmABI5 gene in promoting dandelion to synthesize chicoric acid is provided, and the nucleotide sequence of the dandelion TmABI5 gene is shown in SEQ ID NO. 1.
2. The use according to claim 1, characterized by the steps of:
(1) Constructing a carrier of a dandelion TmAB15 gene;
(2) Transforming the constructed dandelion TmABI5 gene vector into dandelion;
(3) And (5) culturing and screening to obtain the transgenic dandelion with increased chicoric acid content.
3. The use according to claim 2, wherein said transformation is transient transformation by agrobacterium.
4. The use according to claim 2, wherein said vector is a plant expression vector.
5. The use according to claim 4, wherein the plant expression vector is pHellgate-TmABI 5-GFP.
6. The application of the dandelion TmABI5 gene in promoting the expression of the Tm4CL1 gene is provided, and the nucleotide sequence of the dandelion TmABI5 gene is shown as SEQ ID NO. 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310640364.5A CN116716335A (en) | 2023-05-31 | 2023-05-31 | Application of dandelion TmABI5 gene in promoting plant to synthesize chicoric acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310640364.5A CN116716335A (en) | 2023-05-31 | 2023-05-31 | Application of dandelion TmABI5 gene in promoting plant to synthesize chicoric acid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116716335A true CN116716335A (en) | 2023-09-08 |
Family
ID=87872665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310640364.5A Pending CN116716335A (en) | 2023-05-31 | 2023-05-31 | Application of dandelion TmABI5 gene in promoting plant to synthesize chicoric acid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116716335A (en) |
-
2023
- 2023-05-31 CN CN202310640364.5A patent/CN116716335A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111118005B (en) | MiRNA related to rice blast resistance, corresponding precursor and application | |
CN109825510B (en) | Lilium regale LrWRKY2 gene and application thereof | |
CN112501182A (en) | Poplar ERF transcription factor gene and application thereof | |
CN109486831B (en) | Carmine radish anthocyanin biosynthesis regulatory gene RsAN1 and application thereof | |
CN110938617A (en) | Lilium regale LrPAL-1 gene and application thereof | |
CN114231539A (en) | Application of switchgrass SBP-box transcription factor PvSPL6 and recombinant vector thereof | |
XU et al. | OsPIN1a gene participates in regulating negative phototropism of rice roots | |
CN111621516B (en) | Gene transient expression method using in-vivo jujube fruit as material | |
CN117025626A (en) | Tobacco nitrate transporter NtNPF7.4, encoding gene thereof, gene editing vector and application | |
CN114717241B (en) | Rice salt tolerance related gene OsMSRFP, encoding protein and application thereof | |
CN114214332B (en) | Tianmu rehmannia anthocyanin related gene RcMYB1 and application thereof | |
CN105695479B (en) | Chrysanthemum symmetry gene CmCYC2c and application thereof | |
CN110106171A (en) | Long-chain non-coding RNA and its application in regulation plant frigostabile | |
CN116716335A (en) | Application of dandelion TmABI5 gene in promoting plant to synthesize chicoric acid | |
CN108440658B (en) | Rice chloroplast ribosomal protein coding gene OsWGL2 and application thereof | |
CN113061602A (en) | High-flux promoter variation creating method | |
CN112048507A (en) | Cloning and application of miRNA for enhancing rice blast resistance | |
CN116987712A (en) | Taraxacum TmHY5 gene, expression protein and application thereof | |
CN112251438B (en) | Application of promoter of plant high-temperature inducible gene AT3G56970 in improvement of plant stress resistance | |
CN114149993B (en) | lncRNA for regulating and controlling content of soluble sugar in plants and application thereof | |
CN112048490B (en) | Cotton silk/threonine protein phosphatase GhTPOPP 6 and coding gene and application thereof | |
CN117843745A (en) | Application of PpSWEET2a gene in regulation and control of gummosis resistance of peach | |
CN118240045A (en) | Grape salt stress regulation gene VvPUB and application thereof in salt stress regulation | |
CN117925645A (en) | Limonium bicolor gene LbAP/ERF 32 and application thereof | |
CN118064408A (en) | GmMMP1 protein interacted with soybean mosaic virus protein, gene thereof, method for improving resistance of soybean to soybean mosaic virus and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |